[go: up one dir, main page]

BR9510462A - Micropartículas reticuladas e seu uso como veículos terapéuticos - Google Patents

Micropartículas reticuladas e seu uso como veículos terapéuticos

Info

Publication number
BR9510462A
BR9510462A BR9510462A BR9510462A BR9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A
Authority
BR
Brazil
Prior art keywords
cross
microparticles
vehicles
linked
linked microparticles
Prior art date
Application number
BR9510462A
Other languages
English (en)
Inventor
Andrew Derek Sutton
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of BR9510462A publication Critical patent/BR9510462A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9510462A 1994-12-16 1995-12-14 Micropartículas reticuladas e seu uso como veículos terapéuticos BR9510462A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94309417 1994-12-16
PCT/GB1995/002925 WO1996018388A2 (en) 1994-12-16 1995-12-14 Cross-linked microparticles and their use as therapeutic vehicles

Publications (1)

Publication Number Publication Date
BR9510462A true BR9510462A (pt) 1998-12-15

Family

ID=8217949

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510462A BR9510462A (pt) 1994-12-16 1995-12-14 Micropartículas reticuladas e seu uso como veículos terapéuticos

Country Status (19)

Country Link
EP (1) EP0796090B1 (pt)
JP (1) JP4350165B2 (pt)
CN (1) CN1175208A (pt)
AT (1) ATE234080T1 (pt)
AU (1) AU692019B2 (pt)
BR (1) BR9510462A (pt)
CA (1) CA2207077C (pt)
CZ (1) CZ183797A3 (pt)
DE (1) DE69529917T2 (pt)
DK (1) DK0796090T3 (pt)
ES (1) ES2191721T3 (pt)
FI (1) FI972546A7 (pt)
HU (1) HUT77369A (pt)
NO (1) NO972554D0 (pt)
NZ (1) NZ297072A (pt)
PL (1) PL321018A1 (pt)
PT (1) PT796090E (pt)
WO (1) WO1996018388A2 (pt)
ZA (1) ZA9510702B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
EP0914096B1 (en) * 1996-05-17 2003-08-13 Elan Drug Delivery Limited Microparticles and their use in wound therapy
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
GB9615435D0 (en) 1996-07-23 1996-09-04 Andaris Ltd Spray-dried product and its therapeutic use
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
US5961459A (en) * 1996-10-19 1999-10-05 Andaris Limited Use of hollow microcapsules in diagnosis and therapy
AU718956B2 (en) * 1996-10-21 2000-05-04 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
WO1998033486A1 (en) * 1997-01-30 1998-08-06 Quadrant Healthcare (Uk) Limited Microparticles and their use in cancer treatment
CA2294494A1 (en) 1997-06-05 1998-12-10 Richard C. K. Yen Fibrinogen-coated microspheres
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
WO2005066214A1 (ja) * 2004-01-07 2005-07-21 Seikagaku Corporation ヒアルロン酸誘導体及びそれを含む薬剤
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
GB0814302D0 (en) * 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
EP2216054A1 (en) 2009-02-06 2010-08-11 ProFibrix BV Biodegradable extravascular support
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
CN102724968A (zh) 2010-01-08 2012-10-10 普罗菲布瑞克斯公司 干粉血纤蛋白密封剂
NO20110653A1 (no) 2011-05-02 2012-11-05 Spiro Medical As Respirasjonsovervakning
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0494417T3 (da) * 1991-01-10 1996-05-13 Basf Corp Fremgangsmåde til tværbinding af gelatine og til inkorporering af et materiale deri
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents

Also Published As

Publication number Publication date
ATE234080T1 (de) 2003-03-15
NO972554L (no) 1997-06-05
PL321018A1 (en) 1997-11-24
FI972546L (fi) 1997-07-04
MX9704503A (es) 1997-10-31
PT796090E (pt) 2003-07-31
HUT77369A (hu) 1998-03-30
CN1175208A (zh) 1998-03-04
CA2207077A1 (en) 1996-06-20
FI972546A0 (fi) 1997-06-16
WO1996018388A2 (en) 1996-06-20
CA2207077C (en) 2007-02-06
JPH10510527A (ja) 1998-10-13
DK0796090T3 (da) 2003-06-23
DE69529917T2 (de) 2003-12-11
ES2191721T3 (es) 2003-09-16
DE69529917D1 (de) 2003-04-17
AU692019B2 (en) 1998-05-28
EP0796090A2 (en) 1997-09-24
CZ183797A3 (en) 1997-11-12
NZ297072A (en) 1999-03-29
WO1996018388A3 (en) 1996-08-29
NO972554D0 (no) 1997-06-05
AU4184996A (en) 1996-07-03
ZA9510702B (en) 1996-12-17
FI972546A7 (fi) 1997-07-04
JP4350165B2 (ja) 2009-10-21
EP0796090B1 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
BR9510462A (pt) Micropartículas reticuladas e seu uso como veículos terapéuticos
WO2007079276A3 (en) Magnetic nanoscale particle compositions, and therapeutic methods related thereto
NO20000913L (no) Sfæriske mikropartikler inneholdende lineære polysakkarider
ATE204487T1 (de) Behandlung von untereinander vernetzten partikelaggregaten mit latex zur erhöhung der flexibilität von porösen absorbierenden makrostrukturen
MX9605993A (es) Prenda desechable absorbedora de fluidos del cuerpo.
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
WO1995000184B1 (en) Dried hydrogel from hydrophylic-hygroscopic polymer
EP1509246A2 (de) Thermosensitive polymertr ger mit ver nderbarer physikalischer struktur für die biochemische analytik, diagnostik und therapie
ATE251203T1 (de) Absorbierendes quellbares material aus vernetztem polyaspartat
GR3030381T3 (en) Platelet activating factor antagonists.
ES2084825T3 (es) Procedimiento de preparacion de poliamidas entrecruzadas.
FI951549A0 (fi) Kuohkeita absorboivia makrorakenteita, jotka koostuvat sitoutuneista absorboivista hiukkasista, jotka ovat pinnan kautta ristisidotut aminoepikloorihydriibiaddukteihin
JPH0552221B2 (pt)
ATE5235T1 (de) Flocken aus ionenaustauschharzen, ihre herstellung und ihre wiederbelebung und diese flocken verwendendes ionenaustausch- und filtrationsverfahren.
ATE265204T1 (de) Micropartikeln zur verwendung in nadellosen injektion
CN1208344A (zh) 携带颗粒物质和磁体的贴片
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
ATE286081T1 (de) Verfahren zur herstellung von polymerteilchen
Philpott et al. Improved selective cytotoxicity with an antibody-diphtheria toxin conjugate
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
Baciu Nervolus Control of the Phagocytic System
Lou et al. In-vivo and in-vitro targeting of a murine sarcoma by gelatin microparticles loaded with a glycan (PS1)
WO1997035884A8 (en) Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
George et al. Nanobiovesicles for Therapeutic Delivery
RU95105648A (ru) Средство для лечения ран

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law